Facebook Pixel China used to be a cash cow for western companies. Now it’s a test lab. | Mint Kolkata - newspaper - Read this story on Magzter.com
Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

China used to be a cash cow for western companies. Now it’s a test lab.

Mint Kolkata

|

December 01, 2025

For Western companies in China, a new reality has set in: The easy money is gone and competition is only getting fiercer.

- Hannah Miao

As China's economic growth has slowed in recent years, consumers have become choosier about their spending. Meanwhile, the rise of formidable local rivals has crowded the market and driven vicious price wars, eating into profit margins.

International brands are getting more realistic. Their strategies vary by company and industry, but include tailoring products to Chinese tastes, developing them at a faster pace, marketing them differently and lowering prices.

MORE STORIES FROM Mint Kolkata

Mint Kolkata

Mint Kolkata

Sun's rise in the West: a deal that's priced right

Sun Pharma's acquisition of US-based Organon is a financial bargain just for the global business expansion that it enables. But for an R&D boost, Sun may need to look elsewhere

time to read

2 mins

April 28, 2026

Mint Kolkata

Mint Kolkata

Cafés move beyond coffee. Experience is the new draw

India’s café chains are moving beyond coffee-centric formats into desserts, hybrid menus and experience-led stores, as operators look to lift engagement and average spending amid rising profitability pressures.

time to read

2 mins

April 28, 2026

Mint Kolkata

Mobikwik expects margin boost after RBI's NBFC nod

One MobiKwik Systems Ltd expects to see margins improve after the Reserve Bank of India approved its application for a non-banking financial company (NBFO) licence, the company’s top executive told Mint.

time to read

1 mins

April 28, 2026

Mint Kolkata

Sun Pharma acquires Organon: growth engine or debt trap?

With its $11.75 billion acquisition of Organon, Sun Pharmaceutical has embarked on one ofthe most ambitious overseas expansions by an Indian pharma firm.

time to read

1 mins

April 28, 2026

Mint Kolkata

Mint Kolkata

India is pivoting to win the global race for distributed intelligence

The adoption of a framework for relevant AI diffusion across every layer of the economy could catapult the country ahead

time to read

4 mins

April 28, 2026

Mint Kolkata

HEALTH INSURANCE: 3 GOALS, | SYSTEM— BUT NO SIMPLE FIX

The impossible trinity, or trilemma, saysa country cannot havea fixed exchange rate, free capital flowsand independent monetary policy at once; it must choose two.

time to read

2 mins

April 28, 2026

Mint Kolkata

India-New Zealand trade pact: a gateway to Asia-Pacific markets

This free trade agreement will boost bilateral commerce and unlock fresh opportunities for India

time to read

3 mins

April 28, 2026

Mint Kolkata

Mint Kolkata

Alvarez & Marsal looks to deepen India presence over the next year

Alvarez & Marsal (A&M) plans to scale up its corporate finance team in India and expand into new sectors, as the New York-based consulting firm positions itself to capture a rise in dealmaking and sustained capital inflows into the country, senior executives said.

time to read

2 mins

April 28, 2026

Mint Kolkata

Mint Kolkata

Investors dive back into frontier markets

Investors are piling back into some of the riskiest markets, as demand for frontier assets picks up after an initial war-driven selloff.

time to read

2 mins

April 28, 2026

Mint Kolkata

China blocks Meta's $2 billion acquisition of Al firm Manus

China has decided to block Meta Platforms Inc.'s $2 billion acquisition of agentic AI startup Manus, making a surprise move to unwind a controversial deal that's drawn fire for the leakage of technology to the US.

time to read

1 min

April 28, 2026

Listen

Translate

Share

-
+

Change font size